pathogen testing
Rapid and accurate profiling of infection-causing pathogens remains a significant challenge in modern health care. Despite advances in molecular diagnostic techniques, blood culture analysis remains the gold standard for diagnoses. However, this method is too slow and cumbersome to significantly influence the initial management of patients.
Currently, diagnosis relies on nonspecific physiological criteria and culture-based pathogen detection. This results in diagnostic uncertainty, therapeutic delays and the misuse/overuse of antibiotics. An exciting new era of molecular diagnostics for bloodstream infections is emerging through innovations. Infectious disease diagnostics testing is available for viruses, bacteria, parasites, yeast, and antimicrobial resistance genes. It aims to optimize patient management and reduce antibiotic use with clinically actionable results.
respiratory testing (RTI)
A respiratory tract infection (RTI) is any of a number of infectious diseases involving the respiratory tract including the common cold, pneumonia and the flu. It identifies the most common viral and bacterial pathogens that cause an RTI. Testing panels include viruses (influenza, coronavirus and adenovirys), bacteria (pneumoniae, kiebsiella, staphylococcus and streptococcus) and antimicrobial resistance genes.
gastrointestinal testing (GI)
The digestive tract, or GI tract includes the mouth, the digestive tract, esophagus, stomach, and intestines.
GI infections are viral, bacterial or parasitic and cause inflammation of the GI tract. Testing panels include bacteria (vibrio, salmonella), viruses (adenovirus, astrovirus, norovirus, rotavirus, sapovirus), E coli and parasites.
